Weighing up the evidence used by direct-to-consumer stem cell businesses

Volume: 16, Issue: 12, Pages: 2852 - 2860
Published: Dec 1, 2021
Abstract
Hundreds of businesses across the United States offer direct-to-consumer stem-cell-based interventions that have not been approved by the Food and Drug Administration. Here, we characterize the types of evidence used on the websites of 59 stem cell businesses in the Southwest United States to market their services. We identify over a dozen forms of evidence, noting that businesses are less likely to rely on "gold-standard" scientific evidence,...
Paper Details
Title
Weighing up the evidence used by direct-to-consumer stem cell businesses
Published Date
Dec 1, 2021
Volume
16
Issue
12
Pages
2852 - 2860
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.